21Shares files S-1 for spot Solana ETF in the US
Quick Take 21Shares is the second firm in as many days to file to launch a SOL exchange-traded fund in the U.S. Like VanEck, the firm also believes Solana’s native token should be treated as a commodity. The SEC’s Enforcement Division has already said SOL is a security — which may be a serious roadblock to launching these funds, experts say.
Investment firm 21Shares has filed an S-1 form with the U.S. Securities and Exchange Commission for a Solana SOL -3.56% -based exchange-traded fund, one day after rival VanEck submitted a similar filing .
This is the second SOL ETF filing in the U.S. in as many days and confirmation of some analysts’ prediction that VanEck’s June 27 filing would open the floodgates to competitors seeking to launch Solana-based funds.
"21Shares is excited by the potential for an ETF in the US that provides access to the Solana ecosystem. We believe this is a necessary step for the crypto industry and it holds true to our mission to bring to market easily accessible financial products centered around crypto assets,” Andrew Jacobson, head of legal at 21Shares, said in a statement shared with The Block.
SOL was trading at $143 at publication time, down 4% in the past 24 hours, according to The Block’s price page .
The Zurich, Switzerland-based 21Shares already manages a physically-backed Solana Staking exchange-traded product with over $846 million in assets under management. It also manages a bitcoin ETF that trades on the Cboe BZX Exchange.
Likewise, the 21Shares Core Solana ETF would also trade on the Cboe BZX Exchange (as would the VanEck Solana Trust). According to the company’s S-1 filing, redemptions would be made in-kind (i.e., in SOL rather than cash), in line with other “exchange-traded products for spot-market commodities other than SOL.”
Despite increased interested from prospective issuers, legal experts have told The Block it is unlikely SOL ETFs will pass the SEC’s muster for a variety of reasons including the lack of a regulated futures market for SOL and the SEC Enforcement Decision’s previous declaration that the asset is a security.
“While including a crypto token in a CME futures contract has legal precedent, it should not be the sole criterion for ETF eligibility,” Jacobson said, adding “many cryptocurrencies qualify” to become tradable ETFs. “We look forward to expanding access to crypto as an asset class and view the ETF wrapper as one way to do that.”
21Shares SOL fund will custody its funds with Coinbase Custody.
Matthew Sigel, head of research at VanEck, told The Block the time is right for SOL ETF approvals considering the network is as decentralized as Ethereum, which will soon see its own series of ETFs go live.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Asian stock markets collectively declined, South Korean stocks plunged 4.5%, Japanese stocks fell over 1%, and SK Hynix dropped 7%.
All major stock indices in South Korea fell by more than 4%, leading declines in Asia-Pacific markets. SK Hynix plunged over 7%, approaching its lowest point since April. Samsung Electronics fell by more than 3%. The Nikkei 225 dropped 1%, and the TOPIX fell by about 0.9%. SoftBank Group plummeted 6.34%. The MSCI Asia-Pacific Index dropped by about 1%, with eight out of eleven sub-industries recording losses; the number of declining stocks was roughly three times that of advancing stocks. Gold extended its overnight losses, falling another 0.34%.
Deja vu? After another blow to the "AI stock god," AI trading sees a rebound
Goldman Sachs has upgraded CoreWeave’s rating, with several analysts expressing strong support for its fundamentals, alleviating fears of "AI capital expenditure peaking." The Philadelphia Semiconductor Index ended its eight-day losing streak and closed up 1.6%. Previously, "AI stock guru" Aschenbrenner suffered severe losses again, with the average decline of his top seven holdings reaching 18.3%.
Wall Street collectively rushes to "extinguish panic" over CoreWeave: Don't use one company to negate the entire AI cycle!
Barclays pointed out that CoreWeave's approximately $1.5 billion unsecured bonds account for a very small portion of its total $35 billion debt, yet the market is treating them as a barometer for the entire AI capital expenditure cycle. This is similar to how, during the 2023 Silicon Valley Bank crisis, the $4 billion regional bank ETF was used to predict a U.S. recession. Goldman Sachs believes that the market is using the wrong benchmark, noting that unsecured bonds do not represent the real incremental financing cost. JPMorgan states that banks' exposure is secured and the risks are controllable.
Morgan Stanley Covers Eight Biotech Companies at Once! PTC Therapeutics (PTCT.US) and Belite Bio (BLTE.US) Receive Positive Outlook, Multiple Potential Blockbuster Drugs Highlighted
Morgan Stanley recently released a research report covering eight biotechnology companies for the first time, whose businesses involve rare diseases, ophthalmology, pulmonary diseases, and neuropsychiatric disorders.
Crypto prices
More
